Remdésivir précoce pour prévenir l'évolution vers un Covid-19 sévère en ambulatoire. | Rev Med Suisse;18(764-5): 90-91, 2022 01 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Remdésivir précoce pour prévenir l'évolution vers un Covid-19 sévère en ambulatoire.

Meylan, Pascal.

Meylan P; Professeur honoraire, Faculté de biologie et de médecine, Université de Lausanne, 1015 Lausanne.

Rev Med Suisse ; 18(764-5): 90-91, 2022 01 19.

Article in French | MEDLINE | ID: covidwho-1644194

Subject(s)

COVID-19 Drug Treatment; Outpatients; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Outpatients / COVID-19 Drug Treatment Limits: Humans Language: French Journal: Rev Med Suisse Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Outpatients / COVID-19 Drug Treatment Limits: Humans Language: French Journal: Rev Med Suisse Journal subject: Medicine Year: 2022 Document Type: Article